| Literature DB >> 30740958 |
Giorgio Bogani1, Diego Rossetti2, Antonino Ditto2, Fabio Martinelli2, Valentina Chiappa2, Chiara Leone2, Umberto Leone Roberti Maggiore2, Domenica Lorusso2, Francesco Raspagliesi2.
Abstract
OBJECTIVES: Nerve-sparing radical hysterectomy has been implemented in order to reduce pelvic floor dysfunctions in women undergoing radical surgery for cervical cancer. Here, we aimed to investigate if the adoption of laparoscopic surgery impacts on patients' outcomes.Entities:
Keywords: Hysterectomy; Laparoscopy; Urination Disorders; Uterine Cervical Neoplasms
Mesh:
Year: 2018 PMID: 30740958 PMCID: PMC6393638 DOI: 10.3802/jgo.2019.30.e27
Source DB: PubMed Journal: J Gynecol Oncol ISSN: 2005-0380 Impact factor: 4.401
Fig. 1Study design.
Baseline characteristics of patients undergoing nerve-sparing radical hysterectomy via laparoscopic and open abdominal surgery
| Characteristics | Laparoscopy (n=35) | Open surgery (n=35) | p-value | |
|---|---|---|---|---|
| Age (yr) | 41.1 (±6.9) | 44.1 (±12.7) | 0.792 | |
| BMI (kg/m2) | 22.9 (±4.0) | 20.1 (±9.3) | 0.616 | |
| Charlson Comorbidity Index ≥1 (%) | 3 | 4 | 1.00 | |
| Parity | 1.3 (±1.2) | 1.3 (±0.8) | 0.739 | |
| Previous abdominal surgery | 7 (40) | 9 (35) | 0.776 | |
| Histotype | 1.00 | |||
| Squamous cell | 29 (82.9) | 29 (82.9) | ||
| Other | 6 (17.1) | 6 (17.1) | ||
| Stage of disease | 0.961 | |||
| IB1 | 3 (8.6) | 3 (8.6) | ||
| IB2 | 11 (31.4) | 10 (28.6) | ||
| IIA | 9 (25.7) | 11 (31.4) | ||
| IIB-III | 12 (34.3) | 11 (31.4) | ||
| Neoadjuvant chemotherapy | 1.000 | |||
| No | 5 (14.3) | 6 (17.1) | ||
| Yes | 30 (85.7) | 29 (82.9) | ||
| Adjuvant therapy | 1.000 | |||
| No | 25 (71.4) | 24 (68.6) | ||
| Yes | 10 (28.6) | 11 (31.4) | ||
| Follow-up (mon) | 11 (1, 32) | 49.5 (1, 91) | <0.001 | |
Data are presented as number (%), mean (±SD) or median (range).
BMI, body mass index; FIGO, International Federation of Obstetrics and Gynecologists; NACT, neoadjuvant chemotherapy; SD, standard deviation.
Operative results of patients undergoing nerve-sparing radical hysterectomy via laparoscopic and open abdominal surgery
| Characteristics | Laparoscopy (n=35) | Open surgery (n=35) | p-value |
|---|---|---|---|
| Operative time (min) | 249.4 (± 91.5) | 223.0 (± 65.0) | 0.066 |
| Estimated blood loss (mL) | 30.5 (± 11.0) | 190.0 (± 90.4) | <0.001 |
| Blood transfusions | 0 | 5 (14.2) | 0.053 |
| Hospital stay (days) | 3.2 (± 1.2) | 5.4 (± 2.0) | 0.023 |
| Intraoperative complications | 0 | 1 (3.3) | 1.000 |
| 30-day severe postoperative complications, grade 3 or worse | 0 | 2 (5.7) | 0.492 |
Data are presented as number (%) or mean (±SD).
SD, standard deviation.
Pelvic dysfunctions rate for patients undergoing nerve-sparing radical hysterectomy via laparoscopic and open abdominal surgery
| Characteristics | Laparoscopy (n=35) | Open surgery (n=35) | p-value |
|---|---|---|---|
| Pelvic dysfunctions (not yet recovered at 30-day) | 0 | 6 (17.1) | 0.024 |
| Bladder dysfunctions at 30 days | 0 | 5 (14.2) | 0.053 |
| Anorectal dysfunctions at 30 days | 0 | 1 (3.3) | 1.000 |
Data are presented as number (%).
Fig. 2Recovery of bladder function.
Fig. 3Survival outcomes.